Mark A. Goldsmith - Oct 24, 2023 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Stock symbol
RVMD
Transactions as of
Oct 24, 2023
Transactions value $
$17,150
Form type
4
Date filed
10/24/2023, 07:21 PM
Previous filing
Sep 20, 2023
Next filing
Dec 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $17.2K +35K +10.02% $0.49* 384K Oct 24, 2023 Direct F1
holding RVMD Common Stock 35.4K Oct 24, 2023 Trust F2
holding RVMD Common Stock 35.4K Oct 24, 2023 Trust F3
holding RVMD Common Stock 328K Oct 24, 2023 Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -35K -34.16% $0.00 67.4K Oct 24, 2023 Common Stock 35K $0.49 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 174,000 restricted stock units.
F2 Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F3 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F4 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Remarks:

President and Chief Executive Officer